Illumina
ILMN
$5.16 (3.92%)
1D
1W
3M
1Y
5Y
ALL
Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions. The Company operates through segments such as Core Illumina. Core Illumina’s products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Core Illumina consists of its core operations. The Company's portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Seeking Alpha • 1 day ago • ILMN
Illumina, Inc. (ILMN) CFO Ankur Dhingra Hosts Wolfe Research 2024 Healthcare Conference (Transcript)Zacks Investment Research • 1 day ago • ILMN
ILMN Stock Set to Gain From Expansion of TruSight Oncology PortfolioPRNewsWire • 2 days ago • ILMN
Illumina announces expansion of TruSight Oncology portfolioZacks Investment Research • 10 days ago • ILMN
Why Illumina (ILMN) is a Top Momentum Stock for the Long-TermZacks Investment Research • 14 days ago • ILMN
Interpreting Illumina (ILMN) International Revenue TrendsCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.